期刊文献+

培菲康联合酮替酚治疗腹泻肠易激综合征疗效观察 被引量:4

下载PDF
导出
摘要 目的观察培菲康与酮替酚联合应用对肠易激综合征(IBS)的治疗效果。方法对符合罗马II标准的62例腹泻型肠易激综合征患者随机分为培菲康联用酮替酚治疗组与单用培菲康对照组。疗程均为8周。结果治疗组与对照组总有效率较治疗前均有明显提高,治疗组较对照组提高尤为显著,差异有统计学意义(P<0.05)。研究期间未发现明显不良反应。结论培菲康联合酮替酚是一种有效、安全的缓解腹泻型D-IBS症状的药物,治疗腹泻肠易激综合征疗效确切。
作者 何金芳 张玲
出处 《中国实用医药》 2010年第2期165-166,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献33

  • 1杨云生,周殿元,张万岱,张振书,宋于刚.肠易激综合征回盲部肥大细胞的研究[J].中华内科杂志,1997,36(4):231-233. 被引量:47
  • 2桂先勇 柯美云.肠易激综合征.现代胃肠病学[M].北京:科学出版社,1994.1293-1306.
  • 3MMPI全国协作组.中国人使用明尼苏达多相个性测查表的结果分析[J].心理学报,1985,17:346-354.
  • 4文碧珍 潘其英.健康人肠功能紊乱症状调查[J].中华流行病学杂志,1988,9(6):345-349.
  • 5[5]Guilera M,Balboa A,Mearin F.Bowel habit subtypes and temporal patterns in irritable bowel syndrome:systematic review.Am J Gastroenterol 2005;100:1174-1184.
  • 6[6]Cammeri M.Motor function in irritable bowel syndrome.Can J Gastroenterol 1999; 13(suppl A):8A-11A.
  • 7[9]Bouln M,Plourde V,Boivin M,et al.Rectal distention testing in patients with irritable bowel syndrome:sensitivity,specificity,and predictive values of pain sensory thresholds.Gastroenterology 2002;122:1771-1777.
  • 8[10]Poitras P,Poitras R M,Ploarde V,et al.Evaluation of visceral sensitivity in patients with irritable bowel syndrome.Dig Dis Sci 2002;47:914-920.
  • 9[12]Bernstein CN,Frankenstein UN,Rawsthorne P,et al.Cortical mapping of visceral pain in patients with GI disorders using functional magnetic resonance imaging.Am J Gastroenterol 2002;97:319-327.
  • 10[13]Mertz H,Morgan V,Tanner G,et al.Regional cerebral activation in irritable bowel syndrome and control subjects with Painful and nonpainful rectal distention.Gastroenterology 2000;118:842-848.

共引文献523

同被引文献20

  • 1杨欣艳,李世荣.微生态制剂在肠易激综合征治疗中的作用[J].中华医学杂志,2005,85(39):2802-2804. 被引量:16
  • 2功能性胃肠病罗马Ⅲ诊断标准[J].胃肠病学,2006,11(12):761-765. 被引量:746
  • 3Verdu EF,Bercik P,Verma-Oandhu M,et al.Specific probiotic therapyattenuates antibiotic induced visceral hypersensitivity in mice[J]. Gut, 2006,55(5). 182-190.
  • 4Niedzielin K,Kordecki H,Birkenfeld B.A controlled,double- blind,randomizedstudy on the efficacy of Lactobacillus plantarum 299V in patientswith irritable bowel syndrome[J].Eur J Gasroenterol Hepatol,2001,13(lO)=1143-1147.
  • 5CHO H S, PARK J M, LIM C H, et al. Anxiety, depression and quality of life in patients with irritable bowel syndrome[J]. Gut Liver, 2011,5: 29-36.
  • 6DROSSMAN D A, MCKEE D C, SANDLER R S, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and nonpatients with irritable bowel syndrome[J]. Am J Gastroenterol, 2004,99(2) :350-357.
  • 7SOLMAZ M, KAOENTER O L, KAVUK I, et al. Psychological factors in the irritable bowel syndrome[J]. Eur J Med Res, 2003,8(2) :549-556.
  • 8JACKSON J L, O MALLEY P G, TOMKINS G, et al. Treatment of functional gastrointestinal disorders with antidepressant medication: a meta-analysis [J]. Am J Med, 2000, 108(1) :65-72.
  • 9Angèle PM Kerckhoffs,Melvin Samsom,Michel E van der Rest,Joris de Vogel,Jan Knol,Kaouther Ben-Amor,Louis MA Akkermans.Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients[J].World Journal of Gastroenterology,2009,15(23):2887-2892. 被引量:33
  • 10方鹤松,魏承毓.中国腹泻病诊断治疗方案[J].中国实用儿科杂志,1998,13(6):381-384. 被引量:2228

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部